CGD Help: Phenotype Pages
Contents
The Phenotype page presents detailed information about single mutant
phenotypes for a particular gene, along with references for each
observation. This page is accessible from the 'Phenotype' tab of the
Locus Summary and is also linked from the Mutant Phenotypes section of
the Locus Summary, where the phenotype data are presented in summary
form. Data are presented in tabular form on the Phenotype page and may
continue onto additional pages if the number of phenotypes is greater
than 30.
All of the phenotype data for a particular gene may be downloaded to
your computer, as a tab-delimited text file, through the 'Download
Data' links near the top and bottom of the page. A file containing
phenotype data for all genes, 'phenotype_data.tab', is available for
download from CGD's Download
Data page.
What is a mutant phenotype?
Broadly defined, the phenotype of a mutation is the observable effect
that it has on an organism. At CGD, our working definition of a
phenotype is the effect of a mutation on any observable or detectable
feature of Candida cells or cultures. We limit our curation
to those features that are observable in living cells or that occur
in living cells (they may be detected by assays that disrupt cells). For
example, an effect of a mutation in a protease-encoding gene on the
processing of its substrates would be considered a mutant phenotype,
even though biochemical methods must be used to detect the lack of
processing. In contrast, the effect of a mutation in an enzyme on the
in vitro activity of that enzyme would not be curated as a mutant
phenotype. We focus on curating the primary observation rather than
its interpretation: for example, we record the inability of a mutant
strain to grow on medium lacking adenine, rather than the fact that it
has a defect in the adenine biosynthesis pathway. Many of the more detailed,
molecular effects that could be considered phenotypes, as well as the
molecular interpretations of observed effects, are captured in
CGD as Gene Ontology
(GO) annotations. Additionally, only single mutant phenotypes are
curated at present.
How phenotype data are recorded in CGD
In order to facilitate searching and comparison of related phenotypes,
we have developed a system for recording mutant phenotype data that
uses a controlled vocabulary to describe most aspects of the
phenotype.
Mutant phenotype data are presented in a table that contains the
following columns: Experiment type, Mutant information,
Strain background, Phenotype, Anatomical structure, Chemical,
Details, Virulence model, and References.
- Experiment type indicates the method used to detect and
analyze mutant phenotypes. The major experiment types are classical
genetics and
large-scale survey. These indicate the scope of the experiment
and the methods used. Experiments of the type classical genetics are
small-scale, focusing on one or a few genes. Large-scale survey
experiments are those designed with a knowledge of the genome
sequence, often using high-throughput, robot-assisted techniques.
Classical genetics experiments are further categorized into three sub-types
to indicate the ploidy of the strain in which the phenotype was
analyzed: aneuploid, homozygous diploid, and heterozygous
diploid. Note that in cases of aneuploidy, the experiment type refers
to the ploidy of the mutant allele: if it is carried on a triploid
region of the genome, the "aneuploid, classical genetics" experiment
type will be used, but if it is carried on a diploid region of the
genome, the "homozygous diploid, classical genetics" or "heterozygous
diploid, classical genetics" experiment types will be used. For haploid Candida species, such as C. glabrata, "haploid, classical genetics" is used to indicate its ploidy.
Large-scale survey experiments are further categorized into
sub-types reflecting the ploidy of the strain used and also the
experimental methodology:
- systematic mutation set refers to the use of genome-wide
mutant collections.
- competitive growth refers to experiments in which pools of
mutant strains are grown together for many generations to assess their
relative fitness.
- Mutant information includes a description of the impact of
the mutation on the activity of the gene product. Mutations are
classified into the following types:
- activation - the mutation increases the normal activity of a gene
product
- conditional - the activity of the gene product appears wild-type
under some conditions and altered under others
- dominant negative - the mutant gene product negatively affects the activity
of the wild-type gene product, often by dimerizing with it or
titrating one of its targets
- gain of function - the mutation confers a new activity on the gene
product
- misexpression - the gene product is expressed at a developmental
stage, in a cell type, or at a subcellular location different from
that at which the wild-type gene is expressed
- null - synonymous with "loss of function", this type of mutation
abolishes the function of a gene product. Point mutations as well as
complete deletions may result in a null phenotype.
- overexpression - the gene is expressed under control of a strong
promoter and/or on a high copy number plasmid so that the gene product
is present at higher levels than wild-type
- reduction of function - the mutation reduces the activity of the
gene product
- repressible - synonymous with depletion, this represents cases
where there is a reduction of levels of the gene product, often
through the use of a repressible promoter, and may often be combined with an N-degron to
stimulate rapid gene product turnover.
- unspecified - used when the mutant type cannot be determined
Allele names and descriptions, where recorded, are also displayed in
this column of the table. Note that if an allele was named using
an alternative gene name, we have combined it with the CGD
standard gene name: for example, the HGT4-1 allele of the
SNF3 gene is noted as SNF3-(HGT4-1). We make an effort to capture as much allele
information as possible, but are unable to comprehensively record all
alleles.
- Strain background captures the genetic background in which
the mutant phenotype was analyzed, for some of the most commonly used
strains. The strain backgrounds that are recorded at present are:
C. albicans:
- BWP17
- CAF2-1
- CAI-4
- CAI-8
- P37005
- RM1000
- SC5314
- SN152
- SN87
- SN95
- WO-1
- Other
- Not recorded
C. glabrata:
- 2001HT
- 2001T
- BG14
- BG2
- CBS138 (ATCC2001)
- NCCLS84
- Other C. glabrata
If a
study uses a strain backgound that is isogenic to one on this list,
then the parent background is captured. If a background is used that
is not traceable to a strain on this list, or not stated in the paper,
it is noted as 'Other'. Strain background is listed as 'Not recorded' for some
mutant phenotypes that were curated before we began capturing this
information.
- Phenotype combines a term describing the observed feature
with a qualifier that indicates the direction of the change in that
feature relative to wild type (abnormal, arrested, decreased,
decreased duration, decreased rate, delayed, absent, increased,
increased duration, increased rate, premature, normal, normal
duration, normal rate). The entire list
of terms describing observed features, which
are arranged in a hierarchical fashion, is displayed on a page on which
each term is linked to the list of phenotypes annotated using that
term.
In creating the terms that describe phenotypes, we have tried to
strike a balance between using concise, descriptive vocabulary while
also including well-known, commonly used expressions such as
"auxotrophy". These "classical" phenotypes
are not used in combination with a qualifying term (e.g.,
"increased"), since the direction of change relative to wild type is
already implicit. In order to describe phenotypes involving resistance
or sensitivity to drugs, chemicals, or conditions, we use "resistance"
by convention; thus "sensitivity" is described as "decreased
resistance". The exceptions to this are temperature and pheromone
sensitivity, which are so commonly referred to as sensitivity that we have
created individual terms for these concepts. Note that the phenotypes viable and inviable refer to
viability under standard growth conditions.
The controlled-vocabulary terms used to describe phenotypes are a
subset of the terms in the Ascomycete
Phenotype Ontology (APO).
- Anatomical structure indicates any anatomical structure
that is affected by the mutation. Structures are described using terms
from the Fungal
Anatomy Ontology (FAO).
- Chemical indicates any chemical compounds used in the
phenotype assay, most commonly exogenous chemicals that affect the
growth of the mutant strain, but also including nutrient sources,
enzymatic substrates, etc. Chemical compound names are derived, where
possible, from the Chemical Entities of Biological Interest (ChEBI) database maintained at
the European Bioinformatics Institute.
- Details includes additional types of information about the
phenotype, captured as free text:
- Condition summarizes relevant experimental conditions such
as growth media or temperature
- Details includes any additional facts that are important to
understanding the phenotype
- Reporter identifies the protein(s) or RNA(s) that are used
in an experiment to track a process such as transport or localization
of gene products
- Virulence model indicates the type of model system used to
assess the virulence of a mutant. The model systems that are currently
captured are:
- C. elegans infection
- ex vivo model of infection
- guinea pig intravenous infection
- immunosuppressed mouse intravenous infection
- in vitro model of infection
- insect infection
- mouse corneal infection
- mouse cutaneous infection
- mouse gastrointestinal tract infection
- mouse intravenous infection
- mouse mammary gland infection
- mouse oropharyngeal infection
- mouse peritoneal infection
- mouse pulmonary infection
- mouse vaginal infection
- other model
- rabbit corneal infection
- rat oropharyngeal infection
- rat peritoneal infection
- rat vaginal infection
- References lists the publication(s) in which the phenotype
is described, with links to their "CGD Curated Paper" pages as well as
to their abstracts in PubMed.
If there are more than 30 mutant phenotypes recorded for a single
gene, they are separated onto multiple pages. A navigation bar
above the table on each page lists the total number of phenotypes and
pages, and indicates which page you are viewing. Links at the top of
the page allow you to jump down to the 'Download data' link.
Within the table of phenotype data, phenotypes and
chemicals are hyperlinked. Clicking on a phenotype term will
take you to a list of all annotations to that phenotype, with the
associated genes. Clicking on the name of a chemical will take you to
a list of all phenotypes and genes associated with that chemical.
Additional options for searching phenotype data include a search of
the major phenotype terms via the CGD Quick Search, which is
accessed via a text entry box located at the top of most CGD
pages; and a complete search of phenotypes and associated data via
the Expanded Phenotype
Search, which may be accessed from a link on
the Search Options page as well as
from the table of Quick Search results. Please see
the Phenotype Search Help
page for more details on searching phenotype data.
- CGD Pages
- Search Options page
- Expanded Phenotype
Search
- Phenotype Search Help page
- List of phenotype terms in use at CGD
- External Sites
- Open Biomedical
Ontologies site: view and download the Ascomycete Phenotype
Ontology and the Fungal Anatomy Ontology
- Home page of the Fungal
Anatomy Ontology project
- Chemical Entities of Biological Interest (ChEBI)